DexCom, Inc. ( DXCM) - Stock Earnings
DXCM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 267.3 million USD | 1.3 billion USD |
| 2026Q1 | 199.5 million USD | 1.2 billion USD |
| 2026Q2 | 249.1 million USD | 1.3 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
DXCM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 541.5 million USD | 3.6 billion USD |
| 2024 | 576.2 million USD | 4.0 billion USD |
| 2025 | 836.3 million USD | 4.7 billion USD |
| 2026 Est. | — | — |
DXCM
Price: $89.75
52 week price:
Earnings Per Share: 2.53 USD
P/E Ratio: 32.67
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 3.0 million
Ebitda: 6.3 millionMarket Capitalization: 31.2 billion